Law-ref.org Single Convention on Narcotic Drugs
Site search

medic [Global Index]


... Recognizing that the medical use of narcotic drugs continues to be indispensable for the relief of pain and suffering and that adequate provision must be made to ensure the availability of narcotic drugs for such purposes, ...
... Desiring to conclude a generally acceptable international convention replacing existing treaties on narcotic drugs, limiting such drugs to medical and scientific use, and providing for continuous international co-operation and control for the achievement of such aims and objectives, ...


ARTICLE-1: DEFINITIONS     [go to this ARTICLE]
... (i) Consumption in the country or territory for medical and scientific purposes, ...
... 2. For the purposes of this Convention a drug shall be regarded as "consumed" when it has been supplied to any person or enterprise for retail distribution, medical use or scientific research; and "consumption" shall be construed accordingly. ...


ARTICLE-2: SUBSTANCES UNDER CONTROL     [go to this ARTICLE]
... (b) A Party shall, if in its opinion the prevailing conditions in its country render it the most appropriate means of protecting the public health and welfare, prohibit the production, manufacture, export and import of, trade in, possession or use of any such drug except for amounts which may be necessary for medical and scientific research only, including clinical trials therewith to be conducted under or subject to the direct supervision and control of the Party. ...
... 9. Parties are not required to apply the provisions of this Convention to drugs which are commonly used in industry for other than medical or scientific purposes, provided that: ...


ARTICLE-4: GENERAL OBLIGATIONS     [go to this ARTICLE]
... (c) Subject to the provisions of this Convention, to limit exclusively to medical and scientific purposes the production, manufacture, export, import, distribution of, trade in, use and possession of drugs. ...


ARTICLE-9: COMPOSITION AND FUNCTIONS OF THE BOARD     [go to this ARTICLE]
... (a) Three members with medical, pharmacological or pharmaceutical experience from a list of at least five persons nominated by the World Health Organization; and ...
... 4. The Board, in co-operation with Governments, and subject to the terms of this Convention, shall endeavour to limit the cultivation, production, manufacture and use of drugs to an adequate amount required for medical and scientific purposes, to ensure their availability for such purposes and to prevent illicit cultivation, production and manufacture of, and illicit trafficking in and use of, drugs. ...


ARTICLE-12: ADMINISTRATION OF THE ESTIMATE SYSTEM     [go to this ARTICLE]
... 5. The Board, with a view to limiting the use and distribution of drugs to an adequate amount required for medical and scientific purposes and to ensuring their availability for such purposes, shall as expeditiously as possible confirm the estimates, including supplementary estimates, or, with the consent of the Government concerned, may amend such estimates. In case of a disagreement between the Government and the Board, the latter shall have the right to establish, communicate and publish its own estimates, including supplementary estimates. ...


ARTICLE-19: ESTIMATES OF DRUG REQUIREMENTS     [go to this ARTICLE]
... (a) Quantities of drugs to be consumed for medical and scientific purposes; ...


ARTICLE-21: LIMITATION OF MANUFACTURE AND IMPORTATION     [go to this ARTICLE]
... (a) The quantity consumed, within the limit of the relevant estimate, for medical and scientific purposes; ...


ARTICLE-30: TRADE AND DISTRIBUTION     [go to this ARTICLE]
... (i) Require medical prescriptions for the supply or dispensation of drugs to individuals. This requirement need not apply to such drugs as individuals may lawfully obtain, use, dispense or administer in connexion with their duly authorized therapeutic functions; and ...
... 5. A Party shall require that the label under which a drug is offered for sale show the exact drug content by weight or percentage. This requirement of label information need not apply to a drug dispensed to an individual on medical prescription. ...


ARTICLE-49: TRANSITIONAL RESERVATIONS     [go to this ARTICLE]
... (a) The quasi-medical use of opium; ...
... (d) The use of cannabis, cannabis resin, extracts and tinctures of cannabis for non-medical purposes; and ...
... (d) The quasi-medical use of opium must be abolished within 15 years from the coming into force of this Convention as provided in paragraph 1 of article 41. ...
... (f) The use of cannabis for other than medical and scientific purposes must be discontinued as soon as possible but in any case within twenty-five years from the coming into force of this Convention as provided in paragraph 1 of article 41. ...